Doctors Can't Explain Why This Fruit Cuts Blood Sugar by 90%

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

This is a PAID ADVERTISEMENT provided to our customers. Although we have sent you this email, Schaeffer's Investment Research does not endorse this product nor is it responsible for the content of this ad. Furthermore, we make no guarantee or warranty about what is advertised below. Doctors can scream this is "medically impossible" all they want... But they can't deny the lab test results... Every single patient who ate this fruit experienced a dramatic improvement in their diabetes symptoms within days... Their blood sugar dropped almost instantly... And some of them even say it reversed their diabetes! See here the cheap fruit that's making diabetes drugs absolutely useless. Regards, PureHealth Research This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 250 Cincinnati, Ohio 45242 Privacy Policy

Bonus sessions just added for 2019 IES

Oct. 10-12 in DC – Bonus sessions offered to in person attendees ONLY

August 31, 2019 Subscriber, Have you ever wanted to know the ins and outs of options? Or, how you can use this untapped strategy to generate better potential returns than straight-up stock trading? If you answered “yes” to even one of these questions, then claim your seat at the 2019 Irrational Economic Summit in Washington, DC on October 10th-12th. Because you’ll be able to get elite options strategy training from THE industry’s leading options gurus -- live and in person! That means you’ll get direct instruction on how to use options to generate better potential returns. But, this rare opportunity is only open to those who register for the 2019 Irrational Economic Summit by 9/8/2019 at 11:59pm EST. We will not be recording these bonus sessions. You must attend to take advantage. Adam O’Dell As the Chief Investment Strategist at Dent Research, Adam O’Dell knows exactly how to pinpoint prime investment opportunities that guarantee the maximum potential profit with the minimum risk. With his extensive options background and proprietary research system, Adam has been able to teach readers how to play the market and generate amazing gains of 100%... 200%... even 300% on individual three-month-or-less option trades. Lee Lowell Known as America’s #1 income expert, Lee Lowell, is a former Wall Street insider and floor trader with nearly 30 years of market experience. Fed up with the high-stress trading pit life, he now spends his time focusing on helping show everyday people how to collect instant incomewindfalls of $40,000 a year or more. And every time you use even just one of Lee’s options income strategies, you’re LEGALLY obligated to receive instant payouts. Click here right now to reserve your seat at THIS must-attend event of the year. ***SPECIAL LABOR DAY BONUS GIFT: When you register for this event, you’ll get… FREE options trading class with Adam and Lee Access to the best ideas from dozens of other live speakers…AND A RARE free gift from a true government insider. But, hurry, we only have 25 of these special Labor Day gifts left and this opportunity closes 9/2/19! I hope to see you there. Shannon Sands Publisher, Dent Research

Charles Street Publishing Phone: 888-211-2215 Fax: 410-223-2682 Web: http://www.dentresearch.com/contact-us/ Address: 819 North Charles Street, Baltimore MD, 21201. LEGAL NOTICE Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the worldwide web), in whole or in part, is strictly prohibited without the express written permission of Charles Street Publishing. This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment recommendations and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Please note: We sent this e-mail to PHANPHUONGTHANH89.822152@blogger.com because you subscribed to this service. Remove your email from this list: click here

This has never returned less than 400% over 4 years

Dear Reader, Something big is happening in America... and almost no one is paying attention. A completely misunderstood asset is transforming our world... and making people rich (Barron's estimates at least 20,000 people). And get this: If you bought and held this asset over any 4-year period, since 2010... the SMALLEST gains you would have potentially seen would have been a whopping 400%. Even if you bought it on the worst day possible! But that's only the beginning of the story... it's actually much bigger than all of that. One of the smartest and richest men I've ever known has done a full write-up (no video to watch), which explains the full story. I promise you've never seen these ideas, concepts, facts, and figures, discussed anywhere else. That's because there's simply no one in the financial world who thinks like Porter Stansberry. He is truly one of a kind. Take a few minutes to read Porter's latest incredible analysis, right here... Sincerely, Mike Palmer Founding Partner, Stansberry Research P.S. If you want to know why socialism is erupting in America, read Porter's latest. If you want to know why thousands more people are about to lose their jobs, it's all explained here. If you want to know how to potentially make 100-times your money while so many Americans lose potentially everything... this is a must-read. You'll find the full story on our website here... This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 250 Cincinnati, Ohio 45242 Privacy Policy

Take a look: The story of two startups

Inside: Two hand-selected companies to kick off your startup search

You are receiving this email as a part of your subscription to The Startup Investor. To remove your email from this list, unsubscribe here.   The Story of History's Richest Tycoons (and How You Can Be One of Them) Dear Reader, Hi, Neil here. Have you ever heard of Cornelius Vanderbilt or J.P. Morgan? They're pretty iconic guys - and not just because they both netted more than $100 million for themselves back in the day... But also because they used this market to do it... And now, that market is available to YOU. This is where they found Thomas Edison and the Wright brothers... Before anyone else even knew those names. The point is... Morgan was one of the first to invest in electricity, and... The same goes for Vanderbilt but with airplanes. THIS is what made them some of the richest men in history... And now, you can follow in their footsteps. So when the next Steve Jobs, Jeff Bezos, or Elon Musk comes around... You can back these next-generation visionaries from the start. And most importantly, get the chance to make some MASSIVE profits. Click here, and I'll show you how easy it is to get started. Sincerely, Neil Patel Founder, Angels & Entrepreneurs Network P.S. I already found two companies that could turn out to be just as big as - or bigger than - General Electric, Boeing, or Lockheed Martin. Find all the details here.   You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To cancel, or for any other questions or requests, please contact our Customer Service team: Online Phone: 866-310-1498 (North America) 410-501-5876 (International) Mail: Angels & Entrepreneurs | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 Fax: 410-713-4352 Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET. © 2019 Angels & Entrepreneurs, LLC. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs, LLC. 1125 N Charles Street, Baltimore MD 21201. Website | Privacy Policy | Terms & Conditions

9 Must Own Growth Stock for 2019

Dear Reader, Every investor loves growth stocks. Unfortunately they are also the most dangerous stocks to own. Why? Because you are not the only investor aware of the growth potential. Typically it is a widely followed stock that leads to a ton of money chasing the ticker, which pumps up the valuation to premium levels. That is fine as long as the reality of growth keeps up with expectations. However, once the company falls short of the lofty outlook, the stock will collapse...like when a pin pops an overfilled balloon. I don't bring up this potential pitfall as a reason to ignore growth stocks. Rather, the key is to focus on the right kind of growth stocks that increase your odds of success. Like the 9 stocks found in this new special report. In my 40 year investing career I have come to appreciate that the key ingredient is finding growth companies with consistent operational excellence. The best living proof of that is when a company repeatedly beats earnings expectations and provides guidance that the future is even brighter than previously believed. What we in the industry call a "beat and raise" earnings report. The growth stocks in this report all share that quality. In addition, each has received an A rating from our POWR stock ranking system. In short, it is a sign of a stock enjoying positive momentum and likely to stay on an upward trajectory. Get your free copy today by clicking the link below: 9 "Must Own" Growth Stocks for 2019 Wishing you a world of investment success! Steve Reitmeister CEO, StockNews.com This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 250 Cincinnati, Ohio 45242

📝 The Cheat Sheet - August 31, 2019

"The Cheat Sheet" is your weekly roundup of everything that happened in Profit Trends.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

📝 The Cheat Sheet ▾ ▾ ▾ -1.3% YTD -6.7% YTD -18.4% YTD North American Marijuana Index (NAMMAR) U.S. Marijuana Companies Index (UMMAR) Emerging Marijuana Growers Index (EMMAR)   Earnings Season Rocks North American Marijuana Market Read More... Pennsylvania Pipeline Companies Seeing Economic Boom Read More... Marijuana Legality by State: Projected Market Sizes in 2024 Read More... ADVERTISEMENT 2019 Is All About MarijuanaDiscover why more states could legalize marijuana... which stocks could soar... and why you haven't missed the boat! Here's Why KushCo Stock Is Undervalued Watch Now   Well, who has the best network of trusted CBD brands? Of course, we do.   - Nick Kovacevich CEO, KushCo Holdings

Currently, none of the top five cannabis markets in the U.S. are east of the Mississippi River. But that's expected to change within the next five years... A lot of the same multistate operators are weaving their way across the country. They've raised their flags in each state. And they don't want to be left behind by the competition. That means investors looking to capture the most growth need to make sure they have both West and East coast exposure. Read More...

You are receiving this email because you subscribed to Profit Trends. To unsubscribe from Profit Trends, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Profit Trends | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Website: profittrends.com Keep the emails you value from falling into your spam folder. Whitelist Profit Trends. © 2019 The Oxford Club LLC All Rights Reserved

The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.

Unexpected Winners in Purdue's Fall From Grace

Some investors are shaken - but you can benefit from Purdue Pharma's fall from grace.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Browser View

Unexpected Winners in Purdue's Fall From Grace Mable Buchanan, Assistant Managing Editor, The Oxford Club 4 Marijuana Stocks You Should Be Looking At...You've probably seen how fast these stocks move... So make sure you get a copy of "The Marijuana Millionaire's Handbook." It reveals the next four marijuana stocks you should be looking at. Here are the details on how to get a free copy.   Editor's Note: Here at Wealthy Retirement, we'll be honoring Labor Day on Sunday and Monday. Stay tuned as we resume our regular content with Tuesday's Two-Minute Retirement Solution from Steve. Until then, have a restful and safe holiday weekend! But first, check out today's Stat Sheet that looks at how alternative medicine - particularly CBD - can change the game when it comes to pain management. Our friends at Manward Press know this well. In fact, founder Andy Snyder and Dr. Sanjay Jain have teamed up to create the "Seven-Second Pain Relief Challenge." They're offering our readers three free bottles of their naturally based, safe, nonaddictive Pro Restore CBD+. The goal? To show how CBD can make a difference for people who suffer from chronic pain. Last time they made this offer, their treatment sold like lightning. Don't end up on the waitlist - click here to learn more and claim your three free bottles today. Then, read on below for more information about how CBD can change pain management as we know it. - Rachel Gearhart, Associate Franchise Publisher This week, we saw a reckoning in the pharmaceutical sector. It is likely that the companies involved will have to radically change to survive... or else be replaced by competitors. Purdue Pharma, a private healthcare giant, is haunted by its role in America's opioid crisis. On August 20, it entered discussions to decide the price it'll pay. The verdict: $10 billion to $12 billion. Here at Wealthy Retirement, we've talked before about the importance of seeing the healthcare sector like an expert and thoroughly understanding a company before diving in.   Question of the Week   What has been your favorite summer vacation? Click here to answer.   After all, the sector can be extremely volatile in the wake of news like this. Not even established companies like Purdue are immune to negative press. Abbott Laboratories (NYSE: ABT) and Teva Pharmaceutical (NYSE: TEVA) were also charged in several of the lawsuits against Purdue. Teva and Purdue both settled with the state of Oklahoma this spring. Now Purdue is on the brink of bankruptcy. For it and other makers of opioids, this spells disaster. But as we've said before, when it comes to healthcare, there's a winner in every catastrophe... Alternative Medicine Picks Up Speed In a recent Stat Sheet, we asked Wealthy Retirement readers about their most expensive prescriptions. Several of our readers shared that they avoid opioid painkillers because of the risks they pose. Readers like these who embrace alternative medicine are well-positioned to benefit from Purdue's downfall. Take cannabidiol, or CBD, for example. Sales of this natural pain-fighter have doubled every two years since 2014. It's estimated that the American market will reach $22 billion by 2022. (Note, this doesn't even include the growing market for medical marijuana. This figure covers only CBD, which is a totally different compound from THC, the compound in cannabis that causes a high.) Now this safer alternative for pain management is available in doctors' offices, natural food stores and even drugstores like CVS. As Purdue withdraws its aggressive marketing for opioids, CBD is poised to swipe some of its former market share. CBD meets the needs of many pain sufferers, Wealthy Retirement readers included... This week, we asked Wealthy Retirement readers how likely they were to use CBD products. Nearly half of our readers reported that they were very likely to try them - or that they already have. Only 9.2% of our readers plan to avoid CBD products altogether. A combined 43.5% fall somewhere in between. For our readers who have already used CBD products in the past, or who incorporate them into their current wellness regime, we asked how effective they've found the products to be. It's worth noting that patients use CBD for a variety of different reasons. It's even been used as a treatment for cigarette addiction. However, studies in the European Journal of Pain and Journal of Experimental Medicine suggest that it is especially effective for pain management. Still, regardless of which ailment they were treating, more than half our readers who have used CBD products reported that they were effective.   "The best retirement investment you CANNOT have" (Now LEGAL) For 82 years, a ridiculous SEC law allowed ONLY ELITE investors to take stakes in exciting, young private businesses. CNBC even called these types of opportunities "the best retirement investment you CANNOT have." But now that's all changed! SEC rule 4(a)(6) allows you to get in the next hypergrowth winners like Moderna, which turned $100 into $70,000. Details here.   Natural Pain Relief Takes Center Stage Because of its safety, accessibility and effectiveness, CBD (along with other alternative treatments) stands a real chance of emerging from Purdue's rubble as a new leader in pain management. (Investors should be sure to keep an eye on the blooming cannabis industry as well - check out our sister e-letter Profit Trends for more information.) To learn more about how CBD could make a difference in your life, consider taking the "Seven-Second Pain Relief Challenge." Our friend Andy Snyder at Manward Press has partnered with New York Times bestselling author Dr. Sanjay Jain to offer a powerful, nonaddictive, safe CBD product that comes straight from nature. It may have taken our healthcare system decades to discover the power that CBD has to help Americans alleviate pain, but you can discover its effectiveness for yourself in as little as seven seconds. Click here to learn more. Like the market as a whole, the healthcare sector is constantly changing. Even giants like Purdue will lose the spotlight if they fail to adapt. When it comes to your investing and your health, keep an eye out for the companies that commit to putting your best interests first. Disaster may strike in the rest of the sector, but you'll be able to rest easy knowing you're in good hands. Good investing, Mable P.S. Andy and Dr. Sanjay Jain are offering readers three FREE bottles of their natural pain relief product, Pro Restore CBD+. If pain holds too much power over your life, consider taking their Seven-Second Pain Relief Challenge. This completely safe medical alternative can be yours with no prescription necessary... just click here now to learn more.   Click Here to Comment   One Quick Question Do you believe adding an extra $50K to your income THIS YEAR is possible? >>>Click here for YES.<<< Or... >>>Click here for NO.<<< (Whichever you choose, you should see this "guarantee" on how to achieve the extra $50K.)   - More From Wealthy Retirement -     Why I'm Not Attending Any More Weddings Divorce among the boomers increases in likelihood with age.   The Truth About This Inverted Yield Curve An inverted yield curve puts pressure on investors - but you can turn this crazy curveball into a home run.   This 7% Yield Is About to Get Safer This 7%-yielding partnership may bring in less cash this year, but its dividend safety remains secure.       Mysterious Powder Makes Cancer Cells Kill Themselves   Discover the proven cancer-destroying compound that's stunning doctors. Click here for the full details.   You are receiving this email because you subscribed to Wealthy Retirement. To unsubscribe from Wealthy Retirement, click here. Need help with your account? Click here. Have a question or comment for the editor? Click here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Wealthy Retirement | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: 1.855.402.3939 | International: +1.443.353.4057 | Fax: 1.410.329.1923 Website: www.wealthyretirement.com Keep the emails you value from falling into your spam folder. Whitelist Wealthy Retirement. © 2019 The Oxford Club LLC All Rights Reserved The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.